918 Shares in Oracle Corporation $ORCL Acquired by Sprinkle Financial Consultants LLC

Key Points

• Sprinkle Financial Consultants LLC acquired 918 shares of Oracle Corporation valued at approximately $201,000 during the second quarter, adding to a trend of increasing institutional investments in the stock.
• Insider trading activity was notable, with Director William G. Parrett and another insider selling a combined total of 78,247 shares worth over $22 million recently, reflecting significant decreases in their holdings.
• Oracle's stock has seen a recent fluctuation, with a 1-year high of $345.72 and an average analyst rating of "Moderate Buy" alongside an EPS performance that slightly missed projections.

Sprinkle Financial Consultants LLC purchased a new position in shares of Oracle Corporation (NYSE:ORCL - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 918 shares of the enterprise software provider's stock, valued at approximately $201,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ORCL. Redmont Wealth Advisors LLC bought a new stake in Oracle during the first quarter worth $27,000. Inlight Wealth Management LLC bought a new stake in Oracle during the first quarter worth $28,000. Iron Horse Wealth Management LLC lifted its stake in Oracle by 284.9% during the first quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock worth $29,000 after purchasing an additional 151 shares during the last quarter. Sunbeam Capital Management LLC bought a new stake in Oracle during the fourth quarter worth $30,000. Finally, Fourth Dimension Wealth LLC bought a new stake in Oracle during the fourth quarter worth $36,000. 42.44% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director William G. Parrett sold 11,500 shares of the firm's stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $306.00, for a total value of $3,519,000.00. Following the completion of the sale, the director directly owned 17,764 shares in the company, valued at $5,435,784. This trade represents a 39.30% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Clayton M. Magouyrk sold 21,241 shares of the firm's stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $297.11, for a total value of $6,310,913.51. Following the completion of the sale, the insider owned 78,000 shares of the company's stock, valued at approximately $23,174,580. This represents a 21.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 78,247 shares of company stock worth $22,090,505 over the last 90 days. 42.20% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on ORCL shares. CIBC restated a "buy" rating on shares of Oracle in a research note on Monday, June 9th. Westpark Capital increased their price target on Oracle from $195.00 to $246.00 and gave the company a "buy" rating in a research note on Thursday, June 12th. Citigroup reiterated an "outperform" rating on shares of Oracle in a research note on Wednesday, September 10th. TD Cowen increased their price target on Oracle from $325.00 to $375.00 and gave the company a "buy" rating in a research note on Wednesday, September 10th. Finally, Stifel Nicolaus increased their price target on Oracle from $250.00 to $350.00 and gave the company a "buy" rating in a research note on Wednesday, September 10th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-four have assigned a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $303.44.

Oracle Stock Performance

Shares of Oracle stock opened at $309.18 on Friday. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33. The business has a 50-day moving average price of $251.63 and a two-hundred day moving average price of $195.39. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $345.72. The company has a market cap of $878.60 billion, a P/E ratio of 71.57, a PEG ratio of 3.34 and a beta of 1.46.

Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). The firm had revenue of $14.93 billion during the quarter, compared to analyst estimates of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business's quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, analysts anticipate that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be paid a $0.50 dividend. The ex-dividend date is Thursday, October 9th. This represents a $2.00 annualized dividend and a dividend yield of 0.6%. Oracle's dividend payout ratio (DPR) is currently 46.30%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.